Total visits last 3 months
| Last Month Change | 8.96% | 11.14% |
| Avg Visit Duration | 00:00:21 | 00:00:03 |
| Pages per Visit | 1.64 | 1.22 |
| Bounce Rate | 49.51% | 83.11% |
| Compare any site with a free trial | ||
esperion.com VS. 
nexlizet.com
esperion.com
The Investor Relations website contains information about Esperion Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
Global Rank
#1,747,243
nexlizet.com
NEXLIZET® & NEXLETOL®, nonstatin cholesterol medications, approved to lower bad cholesterol & reduce the risk of heart attack, stent placement & bypass
Global Rank
#357,737
esperion.com vs. nexlizet.com Ranking Comparison
Compare esperion.com global ranking trend in the past 3 months vs. nexlizet.com, or dive deeper into esperion.com ranking in its category or country measured against nexlizet.com
Country Rank Last Month
nexlizet.com
#73,304esperion.com
#544,099
Traffic and Engagement
nexlizet.com had more total visits compared to esperion.com in June 2026.
Traffic share by country: esperion.com vs. nexlizet.com
esperion.com vs nexlizet.com country based traffic analysis shows nexlizet.com gets the most traffic from United States, while nexlizet.com gets a smaller share
Top Countries
esperion.com
40.15%
nexlizet.com
59.85%
United States